AV167

• CAT Number: I022695
• Molecular Formula: C22H14N2O4
• Molecular Weight: 370.36
• Purity: 98%
• Synonyms: AV167; AV 167; AV-167
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: [4-(1,3,4-oxadiazol-2-yl)phenyl] 2-benzo[e][1]benzofuran-1-ylacetate
• InChI: InChI=1S/C22H14N2O4/c25-20(28-17-8-5-15(6-9-17)22-24-23-13-27-22)11-16-12-26-19-10-7-14-3-1-2-4-18(14)21(16)19/h1-10,12-13H,11H2
• InChIKey: UPFIGKNEXDPWKJ-UHFFFAOYSA-N
• SMILES: C1=CC=C2C(=C1)C=CC3=C2C(=CO3)CC(=O)OC4=CC=C(C=C4)C5=NN=CO5

AV167（Cat No.:I022695）is a small molecule compound that is being investigated for its potential in treating neurological conditions, particularly Alzheimer’s disease. It functions as an inhibitor of a specific enzyme or protein involved in the progression of neurodegenerative diseases. Preclinical studies suggest that AV167 may help reduce amyloid plaque accumulation and tau protein tangles, which are hallmarks of Alzheimer’s disease. By modulating these pathological processes, AV167 has shown promise in improving cognitive function and slowing disease progression. However, further clinical research is needed to fully assess its efficacy, safety, and potential for long-term therapeutic use.